Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben-Horin

Showing results (311-320 of 362) with videos related to

Pageof 37
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018Yi-Ming He, Ren Mao, Gang Yuan, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2023
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled TrialShomron Ben-Horin, Nir Salomon, Georgios Karampekos, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort studyShomron Ben-Horin, Adi Lahat, Marianne M Amitai, et al.
United European Gastroenterology Journal|August 19, 2020
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort studyNathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel DiseaseHenit Yanai, Shay Matalon, Amir Rosenblatt, et al.
World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.
Inflammatory Bowel Diseases|February 9, 2017
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World ExperienceUri Kopylov, Yulia Ron, Irit Avni-Biron, et al.
Journal of Crohn'S & Colitis|December 14, 2018
Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's DiseaseRen Mao, Yu-Jun Chen, Bai-Li Chen, et al.
Pageof 37

Showing results (311-320 of 362) with videos related to

Sort By:
Pageof 37
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018Yi-Ming He, Ren Mao, Gang Yuan, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2023
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled TrialShomron Ben-Horin, Nir Salomon, Georgios Karampekos, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort studyShomron Ben-Horin, Adi Lahat, Marianne M Amitai, et al.
United European Gastroenterology Journal|August 19, 2020
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort studyNathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel DiseaseHenit Yanai, Shay Matalon, Amir Rosenblatt, et al.
World Journal of Gastroenterology|May 20, 2017
Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceShomron Ben-Horin, Jane M Andrews, Konstantinos H Katsanos, et al.
Inflammatory Bowel Diseases|February 9, 2017
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World ExperienceUri Kopylov, Yulia Ron, Irit Avni-Biron, et al.
Journal of Crohn'S & Colitis|December 14, 2018
Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's DiseaseRen Mao, Yu-Jun Chen, Bai-Li Chen, et al.
Pageof 37